Acute hemodynamic effect of oral ketones in patients with acutely decompensated heart failure and low cardiac output syndrome: a prospective randomized study.

2 September 2024 (11:09 - 11:21)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Marek Sramko

Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)

4 More presentations in this session

Presentation thumbnail

Left ventricular dysfunction, pulmonary congestion, or both and cardiovascular risk after acute myocardial infarction

Doctor J. Tavares Nunes (Toronto, CA)

Abstract Slides Video

Presentation thumbnail

Diuretic therapy strategies in decompensated acute heart failure: a systematic review and network metanalysis

Doctor G. Anastasia (Genoa, IT)

Abstract Slides Video

Presentation thumbnail

Paracetamol and adverse cardiovascular outcomes in patients with heart failure

Doctor Q. Ren (Hong Kong, HK)

Abstract Slides

Presentation thumbnail

Acetazolamide for patients with acute decompensated heart failure: a systematic review and meta-analysis of randomised controlled trials

Doctor M. Kritya (Pune, IN)

Abstract Slides Video

Access the full session

Session thumbnail

Pharmacotherapy for worsening heart failure

The Event

Event poster

ESC Congress 2024

2 September 2024 11:09 CET

You may be interested in

Congress Presentation

Metabolic effects of 14-day oral ketone ester treatment in patients with heart failure with reduced ejection fraction

Congress Presentation

Beneficial metabolic effects of 2-week ketone ester in patients with type 2 diabetes and heart failure with preserved ejection fraction.

Congress Presentation

Effect of exogenous ketone supplementation on cardiac energetics, function, and perfusion in type 2 diabetes, heart failure, and healthy participants- A single center, open labelled clinical study.

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources